Trial
NCT07315503
An Open-label Study of GC012F in Rheumatoid Arthritis.
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Collaborators
—
Condition
Rheumatoid Arthritis
Intervention
LD and GC012F CAR-T Cell Injection
Why stopped
Due to the sponsor's adjustment of the research and development strategy for this clinical trial, this study was prematurely terminated, and no subjects were recruited for this study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-10